V Tagalakis

Summary

Affiliation: McGill University
Country: Canada

Publications

  1. doi request reprint Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort
    Vicky Tagalakis
    Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
    Am J Med 126:832.e13-21. 2013
  2. doi request reprint Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study
    V Tagalakis
    Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, Suite H 410 1, Montreal, QC, H3T 1E2, Canada
    Cancer Causes Control 24:1079-85. 2013
  3. doi request reprint Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients
    Vicky Tagalakis
    Lady Davis Institute for Medical Research, Centre for Clinical Epidemiology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Semin Thromb Hemost 39:127-40. 2013
  4. doi request reprint Men had a higher risk of recurrent venous thromboembolism than women: a large population study
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, QC, Canada
    Gend Med 9:33-43. 2012
  5. pmc Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 7:21. 2007
  6. doi request reprint Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Pharmacoepidemiol Drug Saf 20:304-7. 2011
  7. doi request reprint The effect of warfarin use on clinical stage and histological grade of prostate cancer
    V Tagalakis
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine Road, Suite A 114, Montreal, Quebec, H3T 1E2, Canada
    Pharmacoepidemiol Drug Saf 19:436-9. 2010
  8. ncbi request reprint High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients
    Vicky Tagalakis
    Center for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
    J Thorac Oncol 2:729-34. 2007
  9. ncbi request reprint Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Montreal, QC, Canada
    Lancet Oncol 8:395-402. 2007
  10. ncbi request reprint The effect of anticoagulants on cancer risk and survival: systematic review
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, McGill University, Montreal, Que, Canada
    Cancer Treat Rev 33:358-68. 2007

Detail Information

Publications14

  1. doi request reprint Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort
    Vicky Tagalakis
    Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
    Am J Med 126:832.e13-21. 2013
    ..We determined the incidence and case fatality of venous thromboembolism in a general population...
  2. doi request reprint Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study
    V Tagalakis
    Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, Suite H 410 1, Montreal, QC, H3T 1E2, Canada
    Cancer Causes Control 24:1079-85. 2013
    ..Recent evidence suggests that warfarin use may be associated with a reduced risk of prostate cancer. We aimed to determine whether exposure to warfarin is also associated with a reduced risk of prostate cancer death...
  3. doi request reprint Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients
    Vicky Tagalakis
    Lady Davis Institute for Medical Research, Centre for Clinical Epidemiology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Semin Thromb Hemost 39:127-40. 2013
    ....
  4. doi request reprint Men had a higher risk of recurrent venous thromboembolism than women: a large population study
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, QC, Canada
    Gend Med 9:33-43. 2012
    ..Most reports of sex differences in the risk of recurrent venous thromboembolism (VTE) are based on small or moderate sized cohorts of selected patients with VTE...
  5. pmc Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 7:21. 2007
    ..Elastic compression stockings (ECS) could be helpful in preventing PTS; however, data on their effectiveness are scarce and conflicting...
  6. doi request reprint Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Pharmacoepidemiol Drug Saf 20:304-7. 2011
    ..To determine the test characteristics of diagnostic codes within a medical service claims database for deep vein thrombosis (DVT) and pulmonary embolism (PE)...
  7. doi request reprint The effect of warfarin use on clinical stage and histological grade of prostate cancer
    V Tagalakis
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine Road, Suite A 114, Montreal, Quebec, H3T 1E2, Canada
    Pharmacoepidemiol Drug Saf 19:436-9. 2010
    ..Prolonged warfarin use may decrease the risk of prostate cancer. We aimed to assess the effect of warfarin on histological grade and clinical stage of prostate cancer at diagnosis...
  8. ncbi request reprint High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients
    Vicky Tagalakis
    Center for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
    J Thorac Oncol 2:729-34. 2007
    ..We conducted a retrospective cohort study of patients with NSCLC to determine the incidence of DVT and to characterize predictors of DVT in patients with NSCLC...
  9. ncbi request reprint Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Montreal, QC, Canada
    Lancet Oncol 8:395-402. 2007
    ..Indirect evidence suggests that prolonged treatment with warfarin might be associated with a decreased incidence of urogenital cancer. We aimed to assess this association in a large population-based study...
  10. ncbi request reprint The effect of anticoagulants on cancer risk and survival: systematic review
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, McGill University, Montreal, Que, Canada
    Cancer Treat Rev 33:358-68. 2007
    ....
  11. ncbi request reprint Thrombophilia in short peripheral catheter thrombophlebitis
    Vicky Tagalakis
    Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, RM A 131, Montreal, Quebec, Canada
    Thromb Res 119:587-92. 2007
  12. pmc A comprehensive view of sex-specific issues related to cardiovascular disease
    Louise Pilote
    Division of Internal Medicine, The McGill University Health Centre Research Institute, McGill University, Montreal, Que
    CMAJ 176:S1-44. 2007
    ..However, the interaction between sex-and gender-related factors and CVD outcomes in women remains largely unknown...
  13. ncbi request reprint The epidemiology of peripheral vein infusion thrombophlebitis: a critical review
    Vicky Tagalakis
    Center for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Canada
    Am J Med 113:146-51. 2002
    ..extra nursing time). Although duration of catheterization, catheter-related infection, and catheter material are important risk factors for peripheral vein infusion thrombophlebitis, patient-related risk factors are not well elucidated...
  14. doi request reprint The risk of venous thrombosis, including cerebral vein thrombosis, among women with thrombophilia and oral contraceptive use: a meta-analysis
    N Dayan
    Department of Medicine, Sir Mortimer B Davis Jewish General Hospital, McGill University, Montreal, Canada
    Clin Appl Thromb Hemost 17:E141-52. 2011
    ..25, CI 6.2-32.8). Oral contraceptive use and thrombophilia similarly increase VT risk. Our study confirms an interaction between OCP use and thrombophilia...